Join Christopher Lipinski and Barry Bunin for a discussion on the "Lipinski Rules of 5," which has become the benchmark by which almost all drug discovery analyses are now compared.
Register here: https://info.collaborativedrug.com/lipinski-bunin-ruleof5-0-0
Experts will discuss:
Register here: https://info.collaborativedrug.com/lipinski-bunin-ruleof5-0-0
Experts will discuss:
- Advanced drug discovery & data screening methods
- What is the Lipinski Rule of 5 & How you can go beyond the Rule of 5 to achieve better results
- New technologies to better assess the quality of your screening data
- Experimental culture and sociology as a factor in clustering your results
- How scientists can (and should) respond to the growing opioid addiction crisis – which has actually lowered life expectancy in America
RSS Feed
